SHSeyyed Mohammad Hassan Hashemi

Seyyed Mohammad Hassan Hashemi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seyyed Mohammad Hassan Hashemi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Jafar Akbari

    Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    9 shared publications
  • Katayoun Morteza-Semnani

    Department of Medicinal Chemistry, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    8 shared publications
  • Majid Saeedi

    Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    6 shared publications
  • Seyyed Mobin Rahimnia

    Department of pharmaceutics, faculty of pharmacy, Mazandaran university of medical sciences

    6 shared publications
  • Majid Saeedi

    Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    5 shared publications
  • Mohammad Eghbali

    Department of Pharmaceutics, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    5 shared publications

Latest Publications

  • Open Access

    Synthesis, Structural Characterization, and Sunlight-Induced Photocatalytic Performance of Fe 2 O 3 @CuO Core-Shell Nanocatalyst for Methylene Blue Degradation in the Presence of H 2 O 2

    by Farinam Faryabi, Esmaeil Mohammadian, Galavizh Mandomi, Seyyed Mohammad Hassan Hashemi, Masoud Memar, Amir Shadboorestan, Mahmoud Omidi, Omid Safa

    Introduction: The discharge of colored industrial wastewater—especially organic thiazine dyes, which are toxic, mutagenic, and carcinogenic—poses serious environmental and health problems. Methylene blue, a common dye, is toxic and non-biodegradable, and thus requires effective removal methods. Methods: This study designed and evaluated a photocatalytic degradation system based on Fe2 O3 @CuO nanoparticles for methylene blue removal. The nanoparticles were synthesized via chemical precipitation and characterized using FT-IR, XRD, FESEM, TEM, EDS, and DLS. Their photocatalytic performance was evaluated under sunlight irradiation in a batch system, investigating the effects of catalyst dosage, H2 O2 concentration, and solution pH. Dye concentration was measured using a UV-Vis spectrophotometer. Results: Characterization confirmed the formation of nanoparticles with irregular geometric shapes and uniform distribution. The highest degradation efficiency (99.6%) was achieved within 45 minutes at a pH of 9, a catalyst dosage of 150 mg/L, and 6% H2 O2 . The lowest destruction efficiency (15.3%) occurred in the absence of hydrogen peroxide. Efficiency increased with higher H2 O2 and catalyst doses due to increased radical generation. The nanocatalyst showed excellent reproducibility, retaining 97.1% of its initial efficiency after five cycles with no structural changes. Conclusion: Fe2 O3 @CuO nanoparticles demonstrated high efficiency in the photocatalytic degradation of methylene blue under sunlight. The use of non-toxic, readily available materials, excellent reusability, and a free light source makes this process an economically viable and practical method for treating dye-containing effluents.

  • Arbutin-Loaded Solid Lipid Nanoparticles as Safe and Potent Green Biodegradable Nano systems for Melanin Synthesis Inhibition, Anti-Tyrosinase, and Antioxidant Effects

    by Mahmoud Omidi, Nikoo Ghasabeh Siahkal-Mahaleh, Seyyed Mobin Rahimnia, Hamed Rahmanshenas, Manouchehr Jandaghi, Mojtaba Shabani-Borujeni, Esmaeil Mohammadian, Seyyed Mohammad Hassan Hashemi


  • Green and biocompatible formulation of arbutin encapsulated alginate nanoparticle: improved cytotoxicity against melanoma cancer and potent inhibition of melanin biosynthesis and L-DOPA auto-oxidation

    by Mahmoud Omidi, Nikoo Ghasabeh Siahkal-Mahaleh, Seyyed Mobin Rahimnia, Ali Raofi, Manouchehr Jandaghi, Mojtaba Shabani-Borujeni, Esmaeil Mohammadian, Seyyed Mohammad Hassan Hashemi

    The elevated melanin production within the skin results in a distressing pigmentation disorder called melanoma. This underscores the importance of developing effective therapeutic approaches, such as nano-delivery systems. The primary objective of this research was to create alginate (AL) nanoparticle (NP) in gel dosage for improving targeting of arbutin (ARB) as a lightening substance to cure and manage melanoma cancer. Ionic gelation and ultrasonication method were employed to prepare ARB-AL-NP followed by In-vitro assessment of the NP. Outcomes noticed that the optimum ARB-AL-NP were in the size of 252.333 ± 11.873 nm with zeta potential -14.766 ± 0.862, greater encapsulation 89.831 ± 1.081%, and exhibited sustained release of ARB over 6 h (56%). In vitro MTT analysis confirmed that the optimum formulation had higher cell survival on the HFF cell line than kojic-acid and ARB, however, it showed a greater cytotoxic effect on the B16f10 cell line than other groups. Besides, ARB-AL-NP was established to obstruct melanogenesis to a superior level than kojic-acid and ARB and considerably suppress L-dopa auto-oxidation contrasted to kojic-acid and ARB). The outcomes of this assessment confirmed that the ARB-AL-NP could potentially serve as a prospective nanocarrier for ARB cutaneous application, thus unveiling novel approaches for addressing melanoma complaints.


  • Open Access

    Cumin Essential Oil Nanoemulgel as a Topical Analgesic and Anti-Inflammatory Alternative to NSAIDs

    by Majid Saeedi, Mohammad Eghbali, Katayoun Morteza-Semnani, Fereshteh Talebpour Amiri, Jafar Akbari, Amin Goodarzi, Seyyed Mohammad Hassan Hashemi, Amirhossein Babaei

    Cuminum cyminum L. (cumin) essential oil (CEO) possesses documented analgesic and anti-inflammatory properties, but its topical application is limited by volatility, instability and low aqueous solubility. This study aimed to develop a CEO nanoemulgel and evaluate its physicochemical characteristics, dermal safety and antinociceptive/anti-inflammatory effects in rodent models. The optimized formulation exhibited nanometric droplet size, uniform distribution and acceptable physical stability. In a rat skin irritation test, repeated application of the CEO nanoemulgel did not produce visible erythema or edema compared with the gel base. In mice, the formulation increased tail-flick latency and reduced nociceptive behaviors in both phases of the formalin test, and histological analysis revealed attenuated inflammatory cell infiltration. These findings suggest that the CEO nanoemulgel has promising antinociceptive and anti-inflammatory activity and appears to be well tolerated in short-term preclinical models. Further studies, including long-term safety assessment, mechanistic analysis and clinical trials, are required before CEO nanoemulgel can be considered for use in humans.


  • Open Access

    Green formulation of Menadione-loaded niosome as a skin-lightening preparation: In vitro/In vivo safety evaluation on Wistar rat

    by Majid Saeedi, Katayoun Morteza-Semnani, Jafar Akbari, Seyyed Mobin Rahimnia, Fatemeh Ahmadi, Mohammad Reza Mojaveri, Saghar Ahmadipour, Seyyed Mohammad Hassan Hashemi

    Purpose: In the present research, a green technique (an ultrasonic method) was used to synthesize menadione sodium bisulfite (MSB) niosome (Menasome) which is used to improve dermal delivery and increase anti-melanogenesis activities. Methods: Various cholesterol: surfactant (Chol: Sur) ratios were investigated to optimize the Menasomes. Photon correlation spectroscopy, attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), transmission electron microscopy (TEM), and differential scanning calorimetry (DSC) were employed to characterize the solid state of MSB in nanoparticle form. Additionally, the optimized formulation was used to investigate ex-vivo skin absorption, in vivo skin irritation, in vitro cell survival, and anti-melanogenesis activity. Results: The results exhibited that increasing cholesterol (Chol) declined the average size of the Menasomes from 653.766±25.171 nm to 298.133±8.823 nm and increased entrapment efficiency 30.237±3.4204% to 83.616±2.550 %. The rat skin permeation study indicated that Menasome gel administered more MSB in dermal layers (439.000±36.190μg/cm2 or 23.827±1.964%) than MSB plain gel (286.200± 22.6μg/cm2 or 15.53±1.227%). In both the in vivo skin irritation test and the in vitro cytotoxicity experiment, the extended-release behavior of the enhanced Menasome demonstrated a minimal side effect profile. Furthermore, optimum Menasome inhibited melanin formation (37.426± 1.644% at 15μM) greater than free MSB (57.383±1.654%) considerably (p <0.05). Furthermore, Menasome 7 prevented L-dopa auto-oxidation in higher levels (95.140±2.439%) than pure MSB solution (83.953±1.629%). Conclusion: According to the study's findings, the prepared Menasome could be employed as a viable nanovehicle for MSB dermal delivery, a promising solution for the management of human hyperpigmentation disorders.


  • Open Access

    Green Preparation, Characterization, Wound Healing Assessment, and Histopathological Evaluation of Vitamin A Encapsulated in Niosome and Solid Lipid Nanoparticle

    by Seyyed Mobin Rahimnia, Majid Saeedi, Katayoun Morteza-Semnani, Jafar Akbari, Maryam Ghasemi, Shidrokh Abootorabi, Reza Negarandeh, Mohammad Eghbali, Behrouz Jafarkhani, Mahshid Boskabadi, et al.

    Background: The purpose of the current work was to manufacture vitamin A (Vit A) niosome and solid lipid nanoparticle (SLN) using an ultrasonic approach and to evaluate its effect on wound healing. Methods: The nanoparticles were prepared through an ultrasonication technique and characterized by dynamic light scattering (DLS), and transmission electron microscopy (TEM). Further, the nanoparticles were evaluated for their various parameters such as pH, viscosity, spreadability, stability, in-vitro drug release study, in-vitro cytotoxicity, and in-vivo wound healing. Results: TEM confirmed the spherical nature of the Vit A-niosome and SLN. The Vit A formulations (niosome and SLN) were stable in the accelerated stability test (freeze-thaw cycle). Vit A release from the SLN gel and niosome gel was significantly higher (almost 70 and 80%, respectively) than simple Vit A gel. According to the animal study, the wound healing closure in the Vit A niosomal gel and Vit A SLN gel was greater than the other groups during the 21 days after surgery (P < 0.05) and was close to each other over time and on day 21. Based on histological data, wounds treated with Vit A niosome gel and Vit A-SLN gel had more collagen than the other groups. MDA malondialdehyde (MDA, an end-product of lipid peroxidation) significantly decreased in the Vit A-niosome and Vit A-SLN gel group after 21 days, while glutathione peroxidase (GPx), superoxide dismutase (SOD, an endogenous antioxidant), and hydroxyproline levels demonstrated an increase. Conclusion: The findings of this study revealed that the prepared Vit A nano-formulations could be used as a possible and safe nano-vesicle for Vit A cutaneous delivery thus potentially opening up new prospects for the treatment of wound disorders.


  • Open Access

    Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial

    by Majid Saeedi, Katayoun Morteza-Semnani, Jafar Akbari, Zohreh Hajheydari, Amin Goodarzi, Seyyed Sohrab Rostamkalaei, Seyyed Mohammad Hassan Hashemi, Seyyed Mobin Rahimnia

    Purpose: Spironolactone (SPN), which is classified as an anti-androgen, has demonstrated efficacy in treating acne. This study aimed to utilize ultrasonication to create a chitosan-coated nano lipid carrier (NLC) for enhancing the delivery of SPN to the skin and treating acne. Methods: Various Hydrophilic-Lipophilic Balance (HLB) values were investigated to optimize the SPN-NLCs. Photon correlation spectroscopy, attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), transmission electron microscopy (TEM), and differential scanning calorimetry (DSC) were employed to characterize the solid state of SPN in nanoparticle form. Additionally, the optimized formulation was used in a double-blind, randomized clinical trial. Results: Reducing the HLB of the surfactant mixtures resulted in a reduction in the size of SPN-NLCs. The formula with the smallest particle diameter (238.4±0.74 nm) and the lowest HLB value (9.65) exhibited the highest encapsulation efficiency of 79.88 ± 1.807%. Coating the optimized SPN-NLC with chitosan increased the diameter, PDI, zeta potential, and encapsulation efficiency. In vitro skin absorption studies demonstrated sustained release profiles for chitosan-coated SPN-NLC. In the double-blind trial, a gel containing chitosan-coated SPN-NLC effectively treated mild to moderate acne vulgaris, leading to improved healing and reduced lesion count after 8 weeks of therapy compared to the placebo. It successfully addressed both non-inflammatory and inflammatory lesions without adverse effects on the skin. Conclusion: The findings indicate that chitosan-coated SPN-NLCs have the potential as nanoparticles for targeted SPN delivery to the skin, offering novel options for the treatment of acne vulgaris.


  • Passive Targeted Drug Delivery of Venlafaxine HCl to the Brain by Modified Chitosan Nanoparticles: Characterization, Cellular Safety Assessment, and In Vivo Evaluation

    by Majid Saeedi, Katayoun Morteza-Semnani, Ali Siahposht-Khachaki, Jafar Akbari, Marjan Valizadeh, Alireza Sanaee, Behrouz Jafarkhani, Mohammad Eghbali, Hasan Haji Hossein Zanjani, Seyyed Mohammad Hassan Hashemi, et al.


  • Eco-friendly preparation, characterization, evaluation of anti-melanogenesis/antioxidant effect and in vitro/in vivo safety profile of kojic acid loaded niosome as skin lightener preparation

    by Majid Saeedi, Katayoun Morteza-Semnani, Jafar Akbari, Seyyed Mobin Rahimnia, Amirhossein Babaei, Mohammad Eghbali, Alireza Sanaee, Seyyed Mohammad Hassan Hashemi, Mahmoud Omidi

    In the current study, an ultrasonic approach (as green method) was utilized to prepared kojic acid niosome (kojisome) which aimed to increase the dermal delivery and improving anti-melanogenesis properties. The study’s findings demonstrated that increasing cholesterol enhanced the mean particle size from 68.333 ± 5.686nm to 325.000 ± 15.099nm and entrapment efficiency 0% to 39.341 ± 4.126% of the kojisome. Cholesterol may enhance the number and rigidity of bilayers that induced a size enhancement and entrapment efficiency. The skin permeability test revealed that kojisome gel had more kojic acid in dermal layers (437.563 ± 29.857 μg/cm2 or 16.624 ± 1.379%) than kojic acid plain gel (161.290 ± 14.812 μg/cm2 or 6.128 ± 0.672%). The niosome's lipophilicity allowed for gradual penetration, possibly due to better contact with the skin layers. Also, the extended-release behavior of improved kojisome exhibited high safety profile and low side effect in In vitro cytotoxicity assay, dermal irritation test, and Histo-pathological evaluation. Furthermore, optimum kojisome inhibited melanin formation (53.093 ± 2.985% at 1000 µM) higher than free kojic acid (62.383 ± 1.958%) significantly (p < 0.05). In addition, Kojisome 6 inhibited L-dopa auto-oxidation greater extent (94.806 ± 2.411%) than pure kojic acid solution (72.953 ± 2.728%). Kojisome by delivering and targeting large amount of kojic acid on specific site causes high efficacy in inhibition of melanin synthesis. The observations of this study revealed that the produced kojisome might be used as a potential nano-vehicle for kojic acid dermal administration, thereby opening up innovative options for the treatment of hyperpigmentation problems. Graphical abstract